|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
|
journal
|
December 2009 |
|
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
|
journal
|
March 2013 |
|
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|
journal
|
June 2015 |
|
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
|
journal
|
June 2015 |
|
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
|
journal
|
April 2016 |
|
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
|
journal
|
September 2016 |
|
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
|
journal
|
September 2016 |
|
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
|
journal
|
September 2016 |
|
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
|
journal
|
May 2017 |
|
Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses
|
journal
|
June 2018 |
|
HIV-Host Interactions: Implications for Vaccine Design
|
journal
|
March 2016 |
|
When designing vaccines, consider the starting material: the human B cell repertoire
|
journal
|
August 2018 |
|
Naive CD4+ T Cell Frequency Varies for Different Epitopes and Predicts Repertoire Diversity and Response Magnitude
|
journal
|
August 2007 |
|
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
|
journal
|
August 2013 |
|
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
|
journal
|
November 2015 |
|
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
|
journal
|
September 2016 |
|
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
|
journal
|
November 2016 |
|
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
|
journal
|
January 2018 |
|
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
|
journal
|
April 2018 |
|
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
|
journal
|
May 2018 |
|
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies
|
journal
|
August 2018 |
|
Original antigenic sin: A comprehensive review
|
journal
|
September 2017 |
|
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
|
journal
|
January 2008 |
|
Cloning and expression of murine Ig genes from single B cells
|
journal
|
October 2009 |
|
Arranged Sevenfold: Structural Insights into the C-Terminal Oligomerization Domain of Human C4b-Binding Protein
|
journal
|
April 2013 |
|
A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus
|
journal
|
August 2017 |
|
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
journal
|
April 2013 |
|
Proof of principle for epitope-focused vaccine design
|
journal
|
February 2014 |
|
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
|
journal
|
March 2014 |
|
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
|
journal
|
February 2016 |
|
Role of BCR affinity in T cell–dependent antibody responses in vivo
|
journal
|
May 2002 |
|
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
|
journal
|
August 2015 |
|
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
|
journal
|
October 2015 |
|
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
|
journal
|
February 2009 |
|
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
|
journal
|
December 2015 |
|
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations
|
journal
|
November 2017 |
|
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
|
journal
|
June 2018 |
|
Elicitation of structure-specific antibodies by epitope scaffolds
|
journal
|
September 2010 |
|
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
|
journal
|
October 2010 |
|
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
|
journal
|
June 2012 |
|
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
|
journal
|
October 2012 |
|
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody
|
journal
|
March 2013 |
|
Anti–HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity
|
journal
|
April 2018 |
|
An inverse relationship between T cell receptor affinity and antigen dose during CD4+ T cell responses in vivo and in vitro
|
journal
|
August 1999 |
|
Very Low Affinity B Cells Form Germinal Centers, Become Memory B Cells, and Participate in Secondary Immune Responses When Higher Affinity Competition Is Reduced
|
journal
|
May 2002 |
|
Neutralizing antibodies to HIV-1 induced by immunization
|
journal
|
February 2013 |
|
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
|
journal
|
March 2013 |
|
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
|
journal
|
August 2017 |
|
Progress toward active or passive HIV-1 vaccination
|
journal
|
December 2016 |
|
Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes
|
journal
|
July 2019 |
|
Culture of HEK293-EBNA1 Cells for Production of Recombinant Proteins
|
journal
|
March 2008 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
The CCP4 suite programs for protein crystallography
|
journal
|
September 1994 |
|
HIV-1 neutralizing antibodies: understanding nature's pathways
|
journal
|
June 2013 |
|
Germline-targeting immunogens
|
journal
|
January 2017 |
|
Evolution of B cell analysis and Env trimer redesign
|
journal
|
January 2017 |
|
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
|
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
|
journal
|
July 2011 |
|
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
|
journal
|
July 2011 |
|
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
|
journal
|
October 2011 |
|
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
|
journal
|
October 2011 |
|
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
|
journal
|
March 2013 |
|
Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies
|
journal
|
December 2014 |
|
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
|
journal
|
June 2015 |
|
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
|
journal
|
March 2016 |
|
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
|
journal
|
September 2016 |
|
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
|
journal
|
March 2017 |
|
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen
|
journal
|
July 2018 |
|
The Oligomerization Domain of C4-Binding Protein (C4bp) Acts as an Adjuvant, and the Fusion Protein Comprised of the 19-Kilodalton Merozoite Surface Protein 1 Fused with the Murine C4bp Domain Protects Mice against Malaria
|
journal
|
May 2008 |
|
Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein
|
journal
|
November 2008 |
|
Very Few Substitutions in a Germ Line Antibody Are Required To Initiate Significant Domain Exchange
|
journal
|
August 2010 |
|
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
|
journal
|
August 2010 |
|
Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain
|
journal
|
October 2013 |
|
Diverse Recombinant HIV-1 Envs Fail To Activate B Cells Expressing the Germline B Cell Receptors of the Broadly Neutralizing Anti-HIV-1 Antibodies PG9 and 447-52D
|
journal
|
December 2013 |
|
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
|
journal
|
July 2011 |
|
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design
|
journal
|
February 2012 |
|
The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region
|
journal
|
June 2001 |
|
DNA Vaccination with the Human Immunodeficiency Virus Type 1 SF162 V2 Envelope Elicits Immune Responses That Offer Partial Protection from Simian/Human Immunodeficiency Virus Infection to CD8+ T-Cell-Depleted Rhesus Macaques
|
journal
|
February 2001 |
|
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
|
journal
|
May 2016 |
|
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
|
journal
|
May 2010 |
|
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
|
journal
|
September 2018 |
|
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
|
journal
|
November 2018 |
|
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
|
journal
|
January 2011 |
|
Transplanting Supersites of HIV-1 Vulnerability
|
journal
|
July 2014 |
|
Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
|
journal
|
September 2011 |
|
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
|
journal
|
January 2013 |
|
The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
|
journal
|
November 2013 |
|
HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies
|
journal
|
December 2015 |
|
Emergence and Spreading Potential of Zika Virus
|
journal
|
October 2016 |
|
Cutting Edge: Introduction of an Endopeptidase Cleavage Motif into a Determinant Flanking Region of Hen Egg Lysozyme Results in Enhanced T Cell Determinant Display
|
journal
|
July 2000 |
|
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
|
journal
|
November 2018 |